After seeing “tremendous efficacy” in a phase 1 study, a cancer drug firm is preparing for what it thinks will be a phase 2 pivotal study early next year of its virus therapy for brain tumors. DNAtrix Inc.’s technology is an oncolytic agent, meaning it’s a virus engineered to destroy cancer cells in the body […]
A stealth-mode Colorado startup is raising $2.4 million for the development of a minimally invasive technique for the lacrimal (tear drainage) system.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Molecular diagnostics startup Swift Biosciences Inc. has pulled in a $3 million Series A investment. The Ann Arbor, Michigan-based company will sell molecular biology reagents, which help scientists and doctors conduct genetic tests to identify whether patients are susceptible to specific diseases. Reagents are chemicals used in lab settings to determine whether a chemical reaction […]